novavax fda vaccine - Search News

News

FDA, Novavax and Covid-19

CNN on MSN · 3d

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness.

CBS News on MSN · 8h

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

Clinical Advisor · 7h

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

3d

F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

1don MSN

FDA approves Novavax COVID-19 shot but with unusual restrictions

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

2don MSN

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results